Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

GSK launches Boston-based biotech
June 2009
SHARING OPTIONS:

CAMBRIDGE, Mass.—London-based pharma GlaxoSmithKline plc last month announced the spin-off of Tempero Pharmaceuticals from GSK's Immuno-Inflammation Centre of Excellence in Drug Discovery. The new company will be based in Cambridge, Mass and focus on advances in T-cell biology to develop novel medicines for inflammatory and autoimmune diseases. Further details on the spin-off were not disclosed.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.